D-cycloserine modulates breathlessness related brain activity over pulmonary rehabilitation
Sarah Louise Finnegan,
Olivia K Harrison,
Catherine J. Harmer,
Najib M. Rahman,
Kyle T S Pattinson
Posted 28 Jun 2021
medRxiv DOI: 10.1101/2021.06.24.21259306
Posted 28 Jun 2021
Rationale: For people with Chronic Obstructive Pulmonary Disease (COPD), improvements in breathlessness from pulmonary rehabilitation are neither long lasting nor guaranteed. Previously, we showed that pulmonary rehabilitation induced brain activity changes akin to those seen in exposure based cognitive behavioural therapies (CBT) in other conditions. D-cycloserine is a partial NMDA-receptor agonist which has been shown to enhance CBT. Objectives: Here, we tested whether D-cycloserine would augment the effects of pulmonary rehabilitation on activity in brain areas that process breathlessness expectation. Methods: 72 participants with mild-to-moderate COPD were recruited to a double-blind experimental medicine study running parallel to a pulmonary rehabilitation course. Participants were randomised to 250mg D-cycloserine or matched placebo, administered 15-30 minutes prior to the first four sessions of pulmonary rehabilitation. Brain functional magnetic resonance imaging, self-report questionnaires and clinical measures of respiratory function were collected at three time points: before, during (2-3 weeks) and after pulmonary rehabilitation (6-8 weeks). Measurements: Primary and secondary outcome measures were difference in mean and voxel-wise brain activity across key brain regions of interest. An exploratory analysis determined the interaction with breathlessness-anxiety. Main results: No difference was observed in either primary or secondary outcome measures. However, in the exploratory analysis, D-cycloserine attenuated the relationship between brain activity and breathlessness-anxiety within prefrontal cortex, superior frontal gyrus and precuneus. Conclusions: The observed effects suggest that D-cycloserine augments pulmonary rehabilitation by dampening reactivity to breathlessness cues in brain areas associated with breathlessness expectation and anxiety. This work highlights the opportunity to test brain-active drugs in the context of augmenting behavioural interventions.
- Downloaded 85 times
- Download rankings, all-time:
- Site-wide: 146,459
- In respiratory medicine: 306
- Year to date:
- Site-wide: 73,579
- Since beginning of last month:
- Site-wide: 26,289
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!